No Data
No Data
Unusual Options Activity: NEM, DECK and Others Attract Market Bets, NEM V/OI Ratio Reaches 66.7
HSBC Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $20
Express News | Teva : HSBC Cuts Target Price to $20 From $24
Headache For MOH With Trump's Flip-Flop On Pharma Tariff
Express News | 'FDA Commissioner Says 'No Plans' To Pull Abortion Pill Mifepristone' - Financial Times
BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $20